Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation.

Gasparini SJ, Swarbrick MM, Kim S, Thai LJ, Henneicke H, Cavanagh LL, Tu J, Weber MC, Zhou H, Seibel MJ.

Diabetologia. 2019 Aug;62(8):1463-1477. doi: 10.1007/s00125-019-4887-0. Epub 2019 May 16.

PMID:
31098671
2.

Collagen I-based scaffolds negatively impact fracture healing in a mouse-osteotomy-model although used routinely in research and clinical application.

Lang A, Kirchner M, Stefanowski J, Durst M, Weber MC, Pfeiffenberger M, Damerau A, Hauser AE, Hoff P, Duda GN, Buttgereit F, Schmidt-Bleek K, Gaber T.

Acta Biomater. 2019 Mar 1;86:171-184. doi: 10.1016/j.actbio.2018.12.043. Epub 2019 Jan 5.

PMID:
30616076
3.

Letter--Use of Objectives in Research Articles.

Ogletree RL Jr, Douglas KP, Floyd L, Weber MC, Rawson JR, Pullman M.

J Manag Care Spec Pharm. 2018 May;24(5):488. doi: 10.18553/jmcp.2018.24.5.488.

4.

Continuous corticosterone delivery via the drinking water or pellet implantation: A comparative study in mice.

Gasparini SJ, Weber MC, Henneicke H, Kim S, Zhou H, Seibel MJ.

Steroids. 2016 Dec;116:76-82. doi: 10.1016/j.steroids.2016.10.008. Epub 2016 Nov 2.

PMID:
27815034
5.

Direct observation of polar tweed in LaAlO3.

Salje EK, Alexe M, Kustov S, Weber MC, Schiemer J, Nataf GF, Kreisel J.

Sci Rep. 2016 Jun 2;6:27193. doi: 10.1038/srep27193.

6.

HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells.

Romeo C, Weber MC, Zarei M, DeCicco D, Chand SN, Lobo AD, Winter JM, Sawicki JA, Sachs JN, Meisner-Kober N, Yeo CJ, Vadigepalli R, Tykocinski ML, Brody JR.

Mol Cancer Res. 2016 Jul;14(7):599-611. doi: 10.1158/1541-7786.MCR-15-0448. Epub 2016 Apr 6.

7.

Interplay of chemical structure and magnetic order coupling at the interface between Cr₂O₃ and Fe₃O₄ in hybrid nanocomposites.

Otero-Lorenzo R, Weber MC, Thomas PA, Kreisel J, Salgueiriño V.

Phys Chem Chem Phys. 2014 Oct 28;16(40):22337-42. doi: 10.1039/c4cp01898b.

PMID:
25222634
8.

Structures and magnetism of the rare-earth orthochromite perovskite solid solution LaxSm1-xCrO3.

Daniels LM, Weber MC, Lees MR, Guennou M, Kashtiban RJ, Sloan J, Kreisel J, Walton RI.

Inorg Chem. 2013 Oct 21;52(20):12161-9. doi: 10.1021/ic402029u. Epub 2013 Oct 8.

PMID:
24102287
9.

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

Pineda DM, Rittenhouse DW, Valley CC, Cozzitorto JA, Burkhart RA, Leiby B, Winter JM, Weber MC, Londin ER, Rigoutsos I, Yeo CJ, Gorospe M, Witkiewicz AK, Sachs JN, Brody JR.

Cancer Biol Ther. 2012 Aug;13(10):946-55. doi: 10.4161/cbt.20952. Epub 2012 Aug 1.

10.
11.

Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production.

Skornicka EL, Kiyatkina N, Weber MC, Tykocinski ML, Koo PH.

Cell Immunol. 2004 Nov-Dec;232(1-2):144-56.

PMID:
15882859
12.

Rechallenge of late-onset neutropenia with clozapine.

Small JG, Weber MC, Klapper MH, Kellams JJ.

J Clin Psychopharmacol. 2005 Apr;25(2):185-6. No abstract available.

PMID:
15738753
13.

Differential regulation of Th1/Th2 cytokine responses by placental protein 14.

Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, Rachmilewitz J.

J Immunol. 2004 Nov 1;173(9):5524-30.

14.

New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.

Tykocinski ML, Chen A, Huang JH, Weber MC, Zheng G.

Immunol Res. 2003;27(2-3):565-74. Review.

PMID:
12857999
15.

A receptor for the lipocalin placental protein 14 on human monocytes.

Miller RE, Fayen JD, Chakraborty S, Weber MC, Tykocinski ML.

FEBS Lett. 1998 Oct 9;436(3):455-60.

16.

Antisense modulation of the ICAM-1 phenotype of a model human bone marrow stromal cell line.

Weber MC, Groger RK, Tykocinski ML.

Exp Cell Res. 1998 Oct 10;244(1):239-48.

PMID:
9770366
17.

Bone marrow stromal cell blockade of human leukemic cell differentiation.

Weber MC, Tykocinski ML.

Blood. 1994 Apr 15;83(8):2221-9.

18.

A glycosylphosphatidylinositol-anchored cytokine can function as an artificial cellular adhesin.

Weber MC, Groger RK, Tykocinski ML.

Exp Cell Res. 1994 Jan;210(1):107-12.

PMID:
8269987
19.

Regulation of allogeneic responses by expression of CD8 alpha chain on stimulator cells.

Hambor JE, Weber MC, Tykocinski ML, Kaplan DR.

Int Immunol. 1990;2(9):879-83.

PMID:
2149069
20.

The end of responsible relative liability.

Weber MC.

Except Child. 1987 Oct;54(2):171-5. No abstract available.

PMID:
3678337
21.

Isolation and characterization of BHK cells sensitive to ionizing radiation and alkylating agents.

Evans HH, Horng MF, Weber MC, Glazier KG.

Radiat Res. 1984 Jul;99(1):202-10.

PMID:
6739724
22.

Field trial of metrifonate in the treatment and prevention of schistosomiasis infection in man.

Jewsbury JM, Cooke MJ, Weber MC.

Ann Trop Med Parasitol. 1977 Mar;71(1):67-83.

PMID:
849020
23.

Dose-finding trials of oral oxamniquine in Rhodesia.

de V Clarke V, Blair DM, Weber MC, Garnett PA.

S Afr Med J. 1976 Oct 30;50(46):1867-71.

PMID:
996687
24.

An extended field trial of pyrimethamine combined with dapsone in the prophylaxis of malaria.

Weber MC, de Clarke V, Harwin RM, Shiff CJ.

Cent Afr J Med. 1975 Sep;21(9):187-92. No abstract available.

PMID:
1182795
25.

Oral oxamniquine in the treatment of persistent Schistosoma mansoni bilharziasis.

Blair DM, Weber MC.

Cent Afr J Med. 1975 Feb;21(2):24-6. No abstract available.

PMID:
1122549
26.
27.

A long-term study of a case of schistosoma mansoni subjected to repeated courses of treatment.

Warburton B, Weber MC, Blair DM.

Cent Afr J Med. 1973 Sep:49-52. No abstract available.

PMID:
4747796
28.

Prolonged observation of schistosoma mansoni infections in patients subjected to repeated courses of chemotherapy.

Blair DM, Weber MC.

Cent Afr J Med. 1973 Sep:43-8. No abstract available.

PMID:
4747795
29.
30.

Miracidal hatching in the diagnosis of bilharziasis.

Weber MC.

Cent Afr J Med. 1973 Sep:11-4. No abstract available.

PMID:
4747792
31.

Suppressive therapy in the control of bilharziasis: a comparative trial in African school children.

Clarke Vde V, Weber MC, Blair DM.

Cent Afr J Med. 1973 Sep:32-8. No abstract available.

PMID:
4583840
32.
33.

Schistosomiasis of the male pelvic organs. Severity of infection as determined by digestion of tissue and histologic methods in 300 cadavers.

Gelfand M, Ross CM, Blair DM, Castle WM, Weber MC.

Am J Trop Med Hyg. 1970 Sep;19(5):779-84.

PMID:
5453906
34.

Multiple schistosome infections. An unusual case.

Blair DM, Weber MC.

Cent Afr J Med. 1969 Oct;15(10):9-10. No abstract available.

PMID:
5357781
35.

Macroscopic and microscopic methods in the diagnosis of intestinal bilharziasis.

Blair DM, Weber MC, Clarke Vde V.

Cent Afr J Med. 1969 Oct;15(10):2-8. No abstract available.

PMID:
5357780
36.

Treatment of bilharziasis, detailed observations on a single case.

Blair DM, Weber MC, Clarke Vde V.

Cent Afr J Med. 1969 Oct;15(10):11-7. No abstract available.

PMID:
5357778
37.

The significance of schistosome eggs in the urine after treatment.

Weber MC, Blair DM, Clarke VV.

Cent Afr J Med. 1969 Apr;15(4):82-5. No abstract available.

PMID:
5816353
38.

The distribution of viable and non-viable eggs of schistosoma haematobium in the urine.

Weber MC, Blair DM, de Clarke VV.

Cent Afr J Med. 1969 Feb;15(2):27-30. No abstract available.

PMID:
5814717
39.

Field trial of hycanthone (Etrenol Winthrop) in the treatment of urinary and intestinal bilharziasis.

Clarke Vde V, Blair DM, Weber MC.

Cent Afr J Med. 1969 Jan;15(1):1-6. No abstract available.

PMID:
5779483

Supplemental Content

Loading ...
Support Center